Clinician Perceptions of Timing and Presentation of Drug-Drug Interaction Alerts.


Journal

Applied clinical informatics
ISSN: 1869-0327
Titre abrégé: Appl Clin Inform
Pays: Germany
ID NLM: 101537732

Informations de publication

Date de publication:
05 2020
Historique:
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 1 6 2021
Statut: ppublish

Résumé

Alert presentation of clinical decision support recommendations is a common method for providing information; however, many alerts are overridden suggesting presentation design improvements can be made. This study attempts to assess pediatric prescriber information needs for drug-drug interactions (DDIs) alerts and to evaluate the optimal presentation timing and presentation in the medication ordering process. Six case scenarios presented interactions between medications used in pediatric specialties of general medicine, infectious disease, cardiology, and neurology. Timing varied to include alert interruption at medication selection versus order submission; or was noninterruptive. Interviews were audiotaped, transcribed, and independently analyzed to derive central themes. Fourteen trainee and attending clinicians trained in pediatrics, cardiology, and neurology participated. Coders derived 8 central themes from 929 quotes. Discordance exists between medication prescribing frequency and DDI knowledge; providers may commonly prescribe medications for which they do not recognize DDIs. Providers wanted alerts at medication selection rather than at order signature. Alert presentation themes included standardizing text, providing interaction-specific incidence/risk information, DDI rating scales, consolidating alerts, and providing alternative therapies. Providers want alerts to be actionable, for example, allowing medication discontinuation and color visual cues for essential information. Despite alert volume, participants did not "mind being reminded because there is always the chance that at that particular moment (they) do not remember it" and acknowledged the importance of alerts as "essential in terms of patient safety." Clinicians unanimously agreed on the importance of receiving DDI alerts to improve patient safety. The perceived alert value can be improved by incorporating clinician preferences for timing and presentation.

Identifiants

pubmed: 32698231
doi: 10.1055/s-0040-1714276
pmc: PMC7383060
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

487-496

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

None declared.

Références

J Healthc Inf Manag. 2009 Fall;23(4):38-45
pubmed: 19894486
J Am Med Inform Assoc. 2020 Jun 1;27(6):893-900
pubmed: 32337561
Qual Health Care. 1995 Jun;4(2):80-9
pubmed: 10151618
Int J Med Inform. 2014 Apr;83(4):285-91
pubmed: 24484781
Drug Saf. 2008;31(6):525-36
pubmed: 18484786
Int J Med Inform. 2015 Dec;84(12):1009-18
pubmed: 26391601
N Y State Dent J. 2006 Mar-Apr;72(2):38-46
pubmed: 16711592
AMIA Annu Symp Proc. 2011;2011:1207-16
pubmed: 22195181
Appl Clin Inform. 2014 Jun 18;5(2):571-88
pubmed: 25024770
J Am Med Inform Assoc. 2017 Mar 1;24(2):295-302
pubmed: 27507653
J Am Med Inform Assoc. 2014 Oct;21(e2):e332-40
pubmed: 24780721
Risk Anal. 1999 Jun;19(3):391-400
pubmed: 10765412
Appl Clin Inform. 2014 Sep 03;5(3):802-13
pubmed: 25298818
J Am Med Inform Assoc. 2007 Jan-Feb;14(1):29-40
pubmed: 17068355
J Am Med Inform Assoc. 2008 Jul-Aug;15(4):439-48
pubmed: 18436915
J Am Med Inform Assoc. 2018 May 1;25(5):585-592
pubmed: 29126196
AMIA Annu Symp Proc. 2009 Nov 14;2009:548-52
pubmed: 20351915
JAMA. 2005 Mar 9;293(10):1223-38
pubmed: 15755945
Appl Clin Inform. 2019 Aug;10(4):570-579
pubmed: 31390668
J Am Med Inform Assoc. 2009 Jan-Feb;16(1):40-6
pubmed: 18952941
BMJ. 2013 Mar 13;346:f1616
pubmed: 23487164
BMC Med Inform Decis Mak. 2017 Apr 10;17(1):36
pubmed: 28395667
N Engl J Med. 2003 Sep 18;349(12):1157-67
pubmed: 13679531
Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):941-7
pubmed: 19579216
West J Nurs Res. 2000 Nov;22(7):841-53
pubmed: 11077551
Arch Intern Med. 2003 Nov 24;163(21):2625-31
pubmed: 14638563
BMC Med Inform Decis Mak. 2018 Oct 5;18(1):83
pubmed: 30290797
Qual Health Res. 2010 Oct;20(10):1327-42
pubmed: 20530406
BMJ Qual Saf. 2018 Sep;27(9):718-724
pubmed: 29440481
J Am Med Inform Assoc. 2011 Jul-Aug;18(4):479-84
pubmed: 21571746
Pediatrics. 2014 Aug;134(2):361-72
pubmed: 25022739
Acta Paediatr. 2010 Oct;99(10):1464-6
pubmed: 21050268
J Biomed Inform. 2015 Jun;55:260-71
pubmed: 25817918
J Am Med Inform Assoc. 2015 Nov;22(6):1243-50
pubmed: 25829460

Auteurs

Kate E Humphrey (KE)

Patient Safety and Quality, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Maria Mirica (M)

General Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Shobha Phansalkar (S)

Division of General Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Al Ozonoff (A)

Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, United States.
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States.

Marvin B Harper (MB)

Emergency Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH